XVI EBMWG Workshop, 13–15 April 2023

Barcelona, Spain

Local organizers: Maria Rozman and Elías Campo

IMPACT OF GENETIC ALTERATIONS ON THE CLASSIFICATION OF BONE MARROW MYELOID AND LYMPHOID NEOPLASMS

Topics:

  • SM with an associated hematological neoplasm
  • MPN, MDS/MPN, MDS with genetic alterations that impact their classification
  • Impact of genetic alterations in the classification of LPDs with villous lymphocytes and other small B cell LPD (i.e. indolent MCL, LPL/WM, MZL)

Attendees will also have the possibility to take part in the course virtually (hybrid meeting).

We’re looking forward to an excellent meeting that will bring together worldwide renowned international experts to present the latest developments in bone marrow hematopathology and will give us the opportunity to renew friendships and extend our networks, and jointly explore current and future research directions.

Local Organizing Commitee:

Dr. María Rozman. Barcelona (Spain)
Dr. Elías Campo. Barcelona (Spain)
Dr. Santiago Montes. Santander (Spain)
Dr. Agustín Acevedo. Madrid (Spain)

 

Go to the offcial congress webpage ⧉

EAHP Meeting - Sep 17–22, 2022

Florence, Italy

BONE MARROW SYMPOSIUM AND WORKSHOP
Sunday 18th September 2022

Novel Frontiers in Molecular Diagnosis of Myeloid Neoplasms:
Biomarkers and integrative prognostic models in myeloid diseases

3 sessions:

  • emerging / provisional entities
  • myeloma / immunosecretory diseases / amyloidosis
  • unusual/other neoplasms mainly involving the BM

2 satellite symposia: 

  • Novartis: Update on myeloproliferative neoplasms
  • JAZZ Pharmaceutical: The changing landscape in AML or Do we   still need cytogenetics in AML?

 

Preliminary Program:

08.30 – 08.45 INTRODUCTION

Hans Michael Kvasnicka, University of Witten/Herdecke, Wuppertal, Germany

08.45 – 11.00 BONE MARROW WORKSHOP SESSION 1

Novel Frontiers in Molecular Diagnosis of Myeloid Neoplasms: Biomarkers and integrative prognostic models in myeloid diseases

Chairs: Daniel A. Arber, University of Chicago, Chicago, USA & Alexandar Tzankov, University Hospital Basel, Basel, Switzerland

08.4509.15

KEYNOTE LECTURE

Novel biomarkers and integrative prognostic models in myeloid disease

Torsten Haferlach, Munich Leukemia Laboratory, Munich, Germany

 

10.15 – 11.00 COFFEE BREAK AND POSTER VIEWING

Poster chairs: Konnie Hebeda, Radboud University Medical Centre, Nijmegen, Netherlands & Raffaella Santi, University of Florence, Florence, Italy

 

11.00 – 11.30 BONE MARROW WORKSHOP SESSION 2

EMERGING/PROVISIONAL ENTITIES

Chairs: Leonie Saft, Karolinska University Laboratory, Sweden & María Rozman, Hospital Clínic Barcelona, Barcelona, Spain

11.3011.00

TOPIC LECTURE: Myeloid translocation disorders with eosinophilia

Nick Cross, University of Southampton, UK

 

13.00 – 14.30 LUNCH BREAK AND POSTER VIEWING

13.30 – 14.30 SATELLITE SYMPOSIUM

 

14.30 – 16.00 BONE MARROW WORKSHOP SESSION 2

Myeloma / immunosecretory diseases / amyloidosis

Chairs: Hans Michael Kvasnicka, University of Witten/Herdecke, Wuppertal, Germany & Stefano Lazzi, University Hospital of Siena, Siena, Italy

14.3015.00

TOPIC LECTURE: Bone marrow findings of idiopathic multicentric Castleman disease and POEMS syndrome

Elizaveta Belyaeva, Tulane University School of Medicine, New Orleans, USA

 

16.20 – 16.45 COFFEE BREAK AND POSTER VIEWING

 

16.45 – 18.00 BONE MARROW WORKSHOP SESSION 3

Unusual/other neoplasms mainly involving the bone marrow

Chairs: Ludmila Boudová, Charles University Pilsen, Czech Republic & Umberto Gianelli, University of Milan, Italy

 

18.15 – 19.15 SATELLITE SYMPOSIUM: JAZZ Pharmaceutical

The changing landscape in AML or Do we still need cytogenetics in AML? (To be decided)

 

19.15 – 20. 00 POSTER PRIZE AWARD AND EBMWG BUSINESS MEETING

 

 

Go to the offcial EAHP congress webpage ⧉